Skip to main content

Table 2 Risk factors for active tuberculosis development after transplantation

From: Changes in tuberculosis risk after transplantation in the setting of decreased community tuberculosis incidence: a national population-based study, 2008–2020

Risk factors

 

Univariate

Multivariate

HR (95% CI)

P-value

HR (95% CI)

P-value

Age (years)

0–19

0.48 (0.32, 0.71)

 < 0.001

0.46 (0.31, 0.69)

 < 0.001

20–39

1 (ref.)

 

1 (ref.)

 

40–59

1.18 (0.97, 1.44)

0.09

1.21 (0.99, 1.48)

0.06

 > 60

1.58 (1.26, 1.97)

 < 0.001

1.65 (1.30, 2.08)

 < 0.001

Sex

M

1.412 (1.22, 1.64)

 < 0.001

1.38 (1.19,1.61)

 < 0.001

F

1 (ref.)

 

1 (ref.)

 

Diabetes mellitus

Yes

1.26 (1.10, 1.44)

0.001

1.120 (0.97, 1.29)

0.13

No

1 (ref.)

 

1 (ref.)

 

Hypertension

Yes

1.07 (0.93, 1.22)

0.37

0.97 (0.82, 1.15)

0.73

No

1 (ref.)

 

1 (ref.)

 

Asthma

Yes

0.93 (0.76, 1.14)

0.49

0.97 (0.78, 1.20)

0.77

No

1 (ref.)

 

1 (ref.)

 

COPD

Yes

0.99 (0.73, 1.35)

0.95

0.85 (0.62, 1.18)

0.34

No

1 (ref.)

 

1 (ref.)

 

Liver Cirrhosis

Yes

1.17 (1.00, 1.37)

0.05

0.90 (0.67, 1.20)

0.46

No

1 (ref.)

 

1 (ref.)

 

Chronic kidney disease

Yes

1.00 (0.87, 1.15)

0.96

1.46 (0.98, 2.19)

0.07

No

1 (ref.)

 

1 (ref.)

 

Previous TB history

Yes

1.54 (1.11, 2.14)

0.010

1.48 (1.06, 2.07)

0.02

No

1 (ref.)

 

1 (ref.)

 

Transplantation

Liver

1.17 (0.98, 1.39)

0.08

1.71 (1.04, 2.80)

0.034

Kidney

1 (ref.)

 

1 (ref.)

 

Heart

1.00 (0.63, 1.59)

0.99

1.39 (0.80, 2.41)

0.25

Lung

1.42 (1.78, 2.60)

0.25

1.88 (1.90, 3.92)

0.09

Others

1.59 (0.59, 4.25)

0.36

2.55 (0.89, 7.30)

0.08

Allogeneic HSCT

1.20 (1.00, 1.44)

0.05

2.14 (1.37, 3.34)

 < 0.001

Autologous HSCT

0.68 (0.54, 0.87)

0.002

1.01 (0.64, 1.57)

0.97

  1. CI, confidence interval; COPD, chronic obstructive pulmonary disease; HR, hazard ratio; HSCT, hematopoietic stem cell transplantation; SOT, solid organ transplantation; TB, tuberculosis